Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of nesiritide compared to placebo when
given with standard of care therapies, on kidney function, heart function and the need of
other treatments in heart failure patients undergoing heart bypass graft surgery that
requires the use of a cardiopulmonary bypass machine (CPB pump or heart-lung machine).